Jun 12 2024Chapman University Alzheimer's disease is the world's most common neurodegenerative disease, affecting more than 50 million people globally. Alzheimer's disease is also among the most fatal, landing as one of the top five causes of death worldwide. However, most currently available treatments are limited to alleviating the disease's symptoms.
The study, "Combine use of Donepezil and Memantine increases the probability of five-year survival of Alzheimer's disease patients", was released this month in Communications Medicine, finds that combining the use of the two most common Alzheimer's disease drugs, Donepezil and Memantine, could extend the lives of approximately 303,000 people with Alzheimer's Disease living in the USA beyond five years from diagnosis.
Then, the authors implemented advanced statistical techniques to achieve unbiased estimates of treatment effects and ensure the robustness of results. With these analyses in place, they confirmed a significant, beneficial drug-drug interaction, indicating that the combined use of Donepezil and Memantine significantly increased the probability of five-year survival of Alzheimer's disease patients compared to no drug use and single drug use of Memantine and Donepezil.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Study shows combining joyful activities with 'savoring' therapy shows positive mental health results among young peopleWith rates of depression rising among young people on university campuses, a team of SMU researchers found that combining two different therapeutic approaches demonstrated effectiveness in improving students' overall mental health.
Source: medical_xpress - 🏆 101. / 51 Read more »
Combining two tumor markers can help track down colorectal cancer subtypesColorectal cancer differs from patient to patient. That is why scientists are looking for characteristic tumor markers that allow them to make predictions about the likely response to certain therapies and the individual prognosis. The aim is to identify colorectal cancer subtypes so that these can then be treated in a customized manner.
Source: medical_xpress - 🏆 101. / 51 Read more »
Combining human olfactory receptors with artificial organic synapses and a neural network to sniff out cancerA team of chemical and biological engineers at Seoul National University in the Republic of Korea has developed a proof-of-concept device that could one day lead to the creation of an artificial nose.
Source: medical_xpress - 🏆 101. / 51 Read more »
Combining biomedical data from breast cancer patients could lead to 'groundbreaking discoveries'Studying combined data from the UK Biobank, a unique record of patient information from more than half a million Britons, could help make 'groundbreaking discoveries' in the understanding and treatment of breast cancer, say researchers.
Source: medical_xpress - 🏆 101. / 51 Read more »
I watched both parents die with dementia – now a £99 DNA test reveals I might too...Sun Health Explainer: Dementia and Alzheimer’s disease
Source: TheSun - 🏆 64. / 61 Read more »
Dentist explains the connection between Alzheimer's and oral healthThis week is Dementia Action Week, an event across the UK that aims to get the public to take action to help improve the lives of those living with dementia.
Source: NewsMedical - 🏆 19. / 71 Read more »